Revelation Biosciences (OTCMKTS:REVB – Get Rating) is one of 994 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its rivals? We will compare Revelation Biosciences to related businesses based on the strength of its profitability, risk, analyst recommendations, dividends, institutional ownership, valuation and earnings. Profitability This table compares Revelation Biosciences […]
Revelation Biosciences (OTCMKTS:REVB – Get Rating) is one of 994 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Revelation Biosciences to related companies based on the strength of its analyst recommendations, profitability, valuation, risk, dividends, institutional ownership and earnings. Earnings & Valuation This table compares […]
Revelation Biosciences, Inc. (OTCMKTS:REVB – Get Rating) Director George F. Tidmarsh purchased 26,500 shares of Revelation Biosciences stock in a transaction on Monday, April 17th. The stock was bought at an average cost of $1.16 per share, with a total value of $30,740.00. Following the transaction, the director now directly owns 39,848 shares of the […]
Shares of Revelation Biosciences, Inc. (OTCMKTS:REVB – Get Rating) rose 1.5% on Wednesday . The stock traded as high as $1.40 and last traded at $1.36. Approximately 98,589 shares changed hands during trading, a decline of 64% from the average daily volume of 271,115 shares. The stock had previously closed at $1.34. Analyst Upgrades and […]
Revelation Biosciences, Inc. (OTCMKTS:REVB – Get Rating) rose 1.5% on Wednesday . The company traded as high as $1.40 and last traded at $1.36. Approximately 98,589 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 271,115 shares. The stock had previously closed at $1.34. Analyst Ratings Changes Separately, […]